AnaptysBio, Inc.
ANAB
$17.17
$0.935.73%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 43.63% | 173.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.63% | 173.60% | |||
| Cost of Revenue | 0.89% | 0.51% | |||
| Gross Profit | 104.30% | 60.69% | |||
| SG&A Expenses | -3.48% | 13.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.02% | 2.89% | |||
| Operating Income | 57.51% | 43.56% | |||
| Income Before Tax | 33.67% | 29.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.69% | 29.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.69% | 29.59% | |||
| EBIT | 57.51% | 43.56% | |||
| EBITDA | 57.88% | 43.70% | |||
| EPS Basic | 37.08% | 33.34% | |||
| Normalized Basic EPS | 37.05% | 33.33% | |||
| EPS Diluted | 37.08% | 33.34% | |||
| Normalized Diluted EPS | 37.05% | 33.33% | |||
| Average Basic Shares Outstanding | 5.38% | 5.62% | |||
| Average Diluted Shares Outstanding | 5.38% | 5.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
